Benzinga | Mar 8, 2021 08:29AM EST

BTIG Initiates Coverage On OncoSec Medical with Buy Rating, Announces Price Target of $10

BTIG analyst Thomas Shrader initiates coverage on OncoSec Medical (NASDAQ:ONCS) with a Buy rating and announces Price Target of $10.